drugset / Trial / NCT00517257
Atorvastatin for the Treatment of Retinal Vein Occlusion
Phase 3
Unknown
180 enrolled
University of Toronto
Canadian Heart Research Centre · collabOntario Association of Optometrists · collabPfizer · collabToronto Ophthalmological Society · collabUnity Health Toronto · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The ATORVO study is designed to determine whether atorvastatin (Lipitor) can improve vision, when compared to placebo
Timeline
- Start
- 2007-08
- Primary completion
- —
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 80 mg | Oral |